Analyst Update: Aptevo Therapeutics Inc, PBF Energy Inc, and Cyberark Software Ltd

Analysts are weighing in on Aptevo Therapeutics Inc (NASDAQ:APVO), PBF Energy Inc (NYSE:PBF), and Cyberark Software Ltd (NASDAQ:CYBR)

by Josh Selway

Published on Sep 9, 2016 at 2:48 PM

Analysts are weighing in on biotech Aptevo Therapeutics Inc (NASDAQ:APVO), petroleum refiner PBF Energy Inc (NYSE:PBF), and tech stock Cyberark Software Ltd (NASDAQ:CYBR). Here's a quick roundup of today's brokerage notes on APVO, PBF, and CYBR.

  • APVO is up 12.5% at $2.48, after Piper Jaffray initiated coverage with an "overweight" opinion and a $7 price target, calling the biotech stock a "value-play." Aptevo Therapeutics Inc is new to Wall Street, opening for public trade less than two months ago and hitting a record high of $8.29 in late July. Obviously, it's had a rough time on the charts since then -- today notwithstanding -- attracting bearish traders all the while. For instance, over 9% of APVO's float is currently sold short

  • PBF has dropped 7% to trade at $21.35, after Goldman Sachs downgraded the stock to "sell" from "neutral," and cut its price target to $10 from $23 -- citing several factors, including a poor outlook for East Coast refining. Most analysts are already bearish on PBF Energy Inc, with 60% giving it a "hold" or a "sell" rating. At the same time, more price-target cuts could come the stock's way if it adds to its 42% year-to-date loss. Specifically, PBF's average 12-month price target stands at $28.83, well above current levels.

  • UBS initiated coverage on CYBR with a "neutral" rating and a $56 price target, yet the stock is 5.3% lower at $51.98 amid broad-market headwinds. Still, the shares appear to be finding support near the $51 level, an area that's contained their pullbacks since early July. Cyberark Software Ltd remains 15.1% higher in 2016, and most analysts seem very optimistic. For instance, 11 of 13 brokerage firms recommend buying the stock, and none consider it a "sell." 
Don't miss the market's next move! Sign up now for Schaeffer's Midday Market Check

A Schaeffer's exclusive

6 Sectors for Summer

Access your FREE insider report before it's too late!


  
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


Huge New Legal Marijuana Market Has Shortage Crisis
250 million Europeans have access to medical marijuana. There's already a shortage....
J M Smucker Stock Jammed by Ugly Sales Outlook
J M Smucker's fourth-quarter profits and revenue were better than Wall Street expected
NIO Rises on Record-Breaking Deliveries
Nio stock hit a record high in vehicle deliveries for May
The Next Big Player in U.S. MJ Boom
Most pure-play marijuana stocks in the U.S. trade on the Over-the-Counter stock exchange.